Raymond James Trust N.A. Has $399,000 Position in Avantor, Inc. (NYSE:AVTR)

Raymond James Trust N.A. decreased its holdings in shares of Avantor, Inc. (NYSE:AVTR) by 35.8% in the 3rd quarter, HoldingsChannel reports. The firm owned 15,415 shares of the company’s stock after selling 8,599 shares during the period. Raymond James Trust N.A.’s holdings in Avantor were worth $399,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Boston Partners raised its position in shares of Avantor by 2.2% in the first quarter. Boston Partners now owns 28,561,802 shares of the company’s stock valued at $729,298,000 after purchasing an additional 624,369 shares during the period. Canada Pension Plan Investment Board raised its holdings in Avantor by 6.8% in the 2nd quarter. Canada Pension Plan Investment Board now owns 22,927,325 shares of the company’s stock valued at $486,059,000 after acquiring an additional 1,463,695 shares during the period. 1832 Asset Management L.P. raised its holdings in Avantor by 1,634.9% in the 2nd quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company’s stock valued at $180,839,000 after acquiring an additional 8,038,451 shares during the period. Robeco Schweiz AG lifted its position in Avantor by 5.0% during the second quarter. Robeco Schweiz AG now owns 6,006,985 shares of the company’s stock worth $127,348,000 after acquiring an additional 287,717 shares during the last quarter. Finally, CCLA Investment Management boosted its holdings in shares of Avantor by 8.7% during the second quarter. CCLA Investment Management now owns 5,128,504 shares of the company’s stock worth $109,624,000 after acquiring an additional 408,360 shares during the period. 95.08% of the stock is owned by institutional investors.

Analysts Set New Price Targets

AVTR has been the topic of a number of recent research reports. Wells Fargo & Company lowered their target price on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Robert W. Baird decreased their price target on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research note on Monday, October 28th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $34.00 price target on shares of Avantor in a research report on Thursday, September 26th. UBS Group cut their price objective on shares of Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a report on Tuesday, October 8th. Finally, Barclays lowered their target price on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a report on Friday, October 25th. Three equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $27.57.

Insider Activity

In other news, CAO Steven W. Eck sold 3,525 shares of the company’s stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total transaction of $88,336.50. Following the completion of the transaction, the chief accounting officer now directly owns 29,544 shares in the company, valued at approximately $740,372.64. This represents a 10.66 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.30% of the stock is currently owned by corporate insiders.

Avantor Stock Performance

Avantor stock opened at $21.01 on Wednesday. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. The stock has a market cap of $14.30 billion, a PE ratio of 45.67, a P/E/G ratio of 2.52 and a beta of 1.35. Avantor, Inc. has a 12-month low of $19.59 and a 12-month high of $28.00. The business’s 50-day moving average price is $23.65 and its two-hundred day moving average price is $23.79.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.